Powder: -20°C for 3 years | In solvent: -80°C for 1 year
AZD4747 is a selective and potent inhibitor of the mutant GTPase KRASG12C that crosses the blood-brain barrier and has potential antitumor activity for the study of pancreatic and colorectal adenocarcinoma.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 61,000 |
5 mg | 在庫あり | ¥ 150,000 |
10 mg | 在庫あり | ¥ 226,500 |
25 mg | 在庫あり | ¥ 500,500 |
50 mg | 在庫あり | ¥ 801,000 |
100 mg | 在庫あり | ¥ 1,290,000 |
説明 | AZD4747 is a selective and potent inhibitor of the mutant GTPase KRASG12C that crosses the blood-brain barrier and has potential antitumor activity for the study of pancreatic and colorectal adenocarcinoma. |
分子量 | 440.89 |
分子式 | C24H22ClFN2O3 |
CAS No. | 2489226-14-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 100 mg/mL (226.81 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
AZD4747 2489226-14-2 GPCR/G Protein MAPK Ras Inhibitor inhibitor inhibit